Skip to content

Shattuck Labs, Inc. STTK Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Zymeworks logo
ZymeworksZYME
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
Immunovant, Inc. logo
Immunovant, Inc.IMVT
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s operating lease right-of-use asset amortization?
Shattuck Labs, Inc. (STTK) reported operating lease right-of-use asset amortization of $132K in Q1 2026.
How has Shattuck Labs, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
Shattuck Labs, Inc.'s operating lease right-of-use asset amortization increased by 11.9% year-over-year, from $118K to $132K.
What is the long-term trend for Shattuck Labs, Inc.'s operating lease right-of-use asset amortization?
Over 3 years (2022 to 2025), Shattuck Labs, Inc.'s operating lease right-of-use asset amortization has grown at a 18.8% compound annual growth rate (CAGR), from $302K to $506K.